Merck CEO: Major Breakthrough in Lung Cancer Treatment
During an interview with the FOX Business Network’s Maria Bartiromo Merck CEO Kenneth Frazier said the company has found, based on new data released over the weekend, how its immune therapy drug Keytruda may help to fight advanced lung cancer.
Turing CEO Martin Shkreli Unapologetic for 5,000% Drug Price Hike
The price-gouging pharmaceutical CEO under fire for increasing the price of HIV/AIDS drug, Daraprim from $18 to $750 per pill is unapologetic. During an interview with the FOX Business Network’s Maria Bartiromo, Turing CEO Martin Shkreli explained what was behind the move.
Eli Lilly CEO: Our Drug Prices are Fair
Eli Lilly CEO John Lechleiter thinks the presidential election will drum up more controversy over drug prices. During an interview on FOX Business Network’s Mornings with Maria he said: “If you look back on at least a four-year cycle we see a lot more noise around pricing as we approach the presidential election.”
Nurses Plan To 'Fight Like Hell' for Single-Payer Health Care
Nurses are fighting for Bernie Sanders and single-payer health care.
Nurses Plan To 'Fight Like Hell' for Single-Payer Health Care
Nurses are fighting for Bernie Sanders and single-payer health care.
Cleveland Clinic CEO Has a Warning for All U.S. Hospitals
Fixing America’s health care system is more than addressing rising costs according to Dr. Toby Cosgrove, CEO of the Cleveland Clinic, one of the most technically advanced medical facilities in the country.
J&J's Baby Powder Problem a Blow to Its Bottom Line?
Johnson & Johnson will pay a woman $55 million after claims that its talcum powder caused her to develop ovarian cancer.
Lilly’s New Diabetes Drug Delivers “One of a Kind” Results
In an interview with FOX Business Network’s Maria Bartiromo, Lilly Diabetes President Enrique Conterno discussed the company’s new drug for patients with type-2 diabetes.
Novartis, Google Creating Lenses that Correct Vision in a Millisecond
Novartis is turning to innovation for growth. That’s why the company has decided to partner with Google to develop high tech contact lenses to correct vision and perhaps help diabetics.
Aetna, Humana CEOs Say Industry Consolidation Good for Consumer
After weeks of intense discussions on possible mergers among the five biggest U.S. health insurers, Aetna announced it would buy Humana in a deal valued at $37 billion -- the largest insurance industry deal to date.
Johnson and Johnson CEO: Cancer Research Is Paying Off
Johnson and Johnson has 10 new products in the pharmaceutical pipeline that could potentially earn the company $10 billion in revenue, according to CEO Alec Gorsky.
Exclusive: GlaxoSmithKline CEO Eyes Drugs for Zika
GlaxoSmithKline CEO Andrew Witty on pursuing drugs to battle the Zika virus.
Exclusive: GlaxoSmithKline CEO Eyes Drugs for Zika
GlaxoSmithKline CEO Andrew Witty on pursuing drugs to battle the Zika virus.
Swallow This FDA-Approved Balloon and Lose Weight
FDA approved balloon you swallow promotes weight loss.
Worried About Zika? Here Are The Best Mosquito Repellents
The best-rated mosquito repellents.
Worried About Zika? Here Are The Best Mosquito Repellents
The best-rated mosquito repellents.
ObamaCare Architect: Exchange is Not Falling Apart
Even though UnitedHealthcare (NYSE:UNH) plans to exit most Obamacare exchanges, Dr. Ezekiel Emanuel, who helped design the original Affordable Care Act plan told the FOX Business Network’s Stuart Varney while it’s important to keep big insurers, the nation’s largest health insurer has “never been a big player.”
Mars to Buy VCA for $9.1 Billion
Candy and pet food maker Mars said it would buy VCA, which runs hospitals for animals, for $7.7 billion.
Fiat Chrysler recalls 100K vehicles to fix Takata air bags
Fiat Chrysler is recalling more than 100,000 older trucks and SUVs worldwide to replace potentially dangerous Takata air bag inflators.
UnitedHealth to Buy Surgical Care Affiliates in $2.3B Deal
UnitedHealth Group said on Monday its Optum unit would buy Surgical Care Affiliates Inc in a deal valuing the company at about $2.3 billion.















